Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Manufacturing

Strides Arcolab to buy Aspen's generic drugs business in Australia for $300m By PBR Staff Writer
India-based Strides Arcolab's two subsidiaries have signed definitive agreements with certain wholly-owned subsidiaries of Aspen Pharmacare to acquire their generic pharmaceutical business in Australia, along with certain branded pharmaceutical assets for about A$380m ($300m).
Production & Manufacturing > Manufacturing > News
Eisai introduces in-house developed thyroid cancer drug Lenvima in Japan By PBR Staff Writer
Eisai has introduced its in-house developed new anticancer agent Lenvima Capsule 4mg and 10mg (lenvatinib mesylate, Lenvima) in Japan to treat people with unresectable thyroid cancer.
Production & Manufacturing > Manufacturing > News Emergent signs long-term manufacturing deal with Prometic Life Sciences Emergent BioSolutions (EBS) announced that it has signed a strategic long-term manufacturing agreement with ProMetic Life Sciences. This agreement provides ProMetic access to Emergent's cGMP FDA-licensed biopharmaceuticals facility located in Winnipeg, Manitoba, Canada.
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight

View all Manufacturing news or find news targeted to your interests
Strides Arcolab to buy Aspen's generic drugs business in Australia for $300m
By PBR Staff Writer
India-based Strides Arcolab's two subsidiaries have signed definitive agreements with certain wholly-owned subsidiaries of Aspen Pharmacare to acquire their generic pharmaceutical business in Australia, along with certain branded pharmaceutical assets for about A$380m ($300m).
Production & Manufacturing > Manufacturing > News
Eisai introduces in-house developed thyroid cancer drug Lenvima in Japan
By PBR Staff Writer
Eisai has introduced its in-house developed new anticancer agent Lenvima Capsule 4mg and 10mg (lenvatinib mesylate, Lenvima) in Japan to treat people with unresectable thyroid cancer.
Production & Manufacturing > Manufacturing > News
Emergent signs long-term manufacturing deal with Prometic Life Sciences
Emergent BioSolutions (EBS) announced that it has signed a strategic long-term manufacturing agreement with ProMetic Life Sciences. This agreement provides ProMetic access to Emergent's cGMP FDA-licensed biopharmaceuticals facility located in Winnipeg, Manitoba, Canada.
Production & Manufacturing > Manufacturing > News
Butterworth Laboratories Ltd – Experts in Pharmaceutical Analysis
Butterworth is a UK based contract laboratory providing pharmaceutical analysis in accordance with cGMP to the global pharmaceutical industry. We specialise in Quality Control, Method Development & Validation and Stability Storage & Testing. Our focus and expertise centre on raw materials but we also have experience of finished products and medical devices.
Production & Manufacturing > Manufacturing > Suppliers
Drum Massager
Custom Powder Systems makes a product called a drum massager. It has two sets of C-shaped arms that come in and compress the drum. There's a turntable that turns the drum, compresses it again. It raises up, does additional compressions, and cracks up, breaks up the material.
Production & Manufacturing > Manufacturing > Products
AstraZeneca to build $285m biologics manufacturing facility in Sweden
By PBR Staff Writer
British drugmaker AstraZeneca is investing around $285m to build a new manufacturing facility for biological medicines in Södertälje, Sweden.
Production & Manufacturing > Manufacturing > News
Lannett signs definitive agreement to buy Silarx Pharmaceuticals
Lannett Company has signed a definitive agreement to acquire privately held, Silarx Pharmaceuticals and a related real estate entity, a manufacturer and marketer of liquid generic pharmaceutical products.
Production & Manufacturing > Manufacturing > News
Zambon and Newron launch Xadago in Germany to treat mid- to late-stage Parkinson’s disease
By PBR Staff Writer
Italian pharmaceutical firm Zambon and its partner Newron Pharmaceuticals have launched Xadago (safinamide) in Germany to treat mid- to late-stage Parkinson’s disease (PD).
Production & Manufacturing > Manufacturing > News
FDA approves Baxter's additional manufacturing site for sodium chloride injection in US
By PBR Staff Writer
The US Food and Drug Administration (FDA) has granted approval for Baxter International's supplemental drug application to establish its Sabinanigo facility in Spain, as an approved manufacturing site for 0.9% Sodium Chloride Injection, USP, to be sold in the US market.
Production & Manufacturing > Manufacturing > News
QC Testing
Quality Control (QC) analysis of pharmaceutical raw materials and finished products to cGMP ensures compliance with international standards and ultimately helps to ensure patient safety.
Production & Manufacturing > Manufacturing > Products
View all Manufacturing news or find news targeted to your interests